These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 28902651)

  • 1. Anticoagulant therapy for acute venous thromboembolism.
    Ermiş H; Ermiş N
    Turk Kardiyol Dern Ars; 2017 Sep; 45(6):563-571. PubMed ID: 28902651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating patients with cancer and acute venous thromboembolism.
    Donadini MP; Squizzato A; Ageno W
    Expert Opin Pharmacother; 2016; 17(4):535-43. PubMed ID: 26606049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update in the treatment of venous thromboembolism.
    Garcia DA; Spyropoulos AC
    Semin Respir Crit Care Med; 2008 Feb; 29(1):40-6. PubMed ID: 18302085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community-based treatment of venous thromboembolism with a low-molecular-weight heparin and warfarin.
    Hyers TM; Spyropoulos AC;
    J Thromb Thrombolysis; 2007 Dec; 24(3):225-32. PubMed ID: 17334932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioperative venous thromboembolic disease and the emerging role of the novel oral anticoagulants: an analysis of the implications for perioperative management.
    Mookadam M; Shamoun FE; Ramakrishna H; Obeid H; Rife RL; Mookadam F
    Ann Card Anaesth; 2015; 18(4):517-27. PubMed ID: 26440238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulants.
    Hillis C; Crowther MA
    Thromb Haemost; 2015 Jun; 113(6):1193-202. PubMed ID: 25948149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk of recurrent venous thromboembolism in patients with unprovoked symptomatic deep vein thrombosis and asymptomatic pulmonary embolism.
    Jiménez D; Díaz G; Marín E; Vidal R; Sueiro A; Yusen RD
    Thromb Haemost; 2006 Mar; 95(3):562-6. PubMed ID: 16525588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current management of venous thromboembolism in Japan: Current epidemiology and advances in anticoagulant therapy.
    Nakamura M; Yamada N; Ito M
    J Cardiol; 2015 Dec; 66(6):451-9. PubMed ID: 25896176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RE-COVERY DVT/PE: Rationale and design of a prospective observational study of acute venous thromboembolism with a focus on dabigatran etexilate.
    Ageno W; Casella IB; Han CK; Raskob GE; Schellong S; Schulman S; Singer DE; Kimura K; Tang W; Desch M; Goldhaber SZ
    Thromb Haemost; 2017 Jan; 117(2):415-421. PubMed ID: 27853808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous thromboembolism in centenarians: Findings from the RIETE registry.
    Lacruz B; Tiberio G; Núñez MJ; López-Jiménez L; Riera-Mestre A; Tiraferri E; Verhamme P; Mazzolai L; González J; Monreal M;
    Eur J Intern Med; 2016 Dec; 36():62-66. PubMed ID: 27495947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receipt of anticoagulation after venous thromboembolism diagnoses during delivery hospitalizations.
    O'Shaugnessy F; Syeda SK; Huang Y; D'Alton ME; Wen T; Wright JD; Friedman AM
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6353-6355. PubMed ID: 33855935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost-utility of dabigatran etexilate compared with warfarin in treatment and extended anticoagulation of acute VTE in the UK.
    Jugrin AV; Ustyugova A; Urbich M; Lamotte M; Sunderland T
    Thromb Haemost; 2015 Oct; 114(4):778-92. PubMed ID: 26272227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practical management of rivaroxaban for the treatment of venous thromboembolism.
    Imberti D; Benedetti R
    Clin Appl Thromb Hemost; 2015 May; 21(4):309-18. PubMed ID: 24057396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct oral anticoagulants in the treatment of venous thromboembolism, with a focus on patients with pulmonary embolism: an evidence-based review.
    Gómez-Outes A; Suárez-Gea ML; Lecumberri R; Terleira-Fernández AI; Vargas-Castrillón E
    Vasc Health Risk Manag; 2014; 10():627-39. PubMed ID: 25404858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous Thromboembolism: New Concepts in Perioperative Management.
    Elisha S; Heiner J; Nagelhout J; Gabot M
    AANA J; 2015 Jun; 83(3):211-21. PubMed ID: 26137764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence-Based Therapies for Pharmacologic Prevention and Treatment of Acute Deep Vein Thrombosis and Pulmonary Embolism.
    Jacobs B; Henke PK
    Surg Clin North Am; 2018 Apr; 98(2):239-253. PubMed ID: 29502769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of anticoagulation therapy for venous thromboembolism.
    Bounameaux H; Perrier A
    Hematology Am Soc Hematol Educ Program; 2008; ():252-8. PubMed ID: 19074092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial.
    Lee AYY; Kamphuisen PW; Meyer G; Bauersachs R; Janas MS; Jarner MF; Khorana AA;
    JAMA; 2015 Aug; 314(7):677-686. PubMed ID: 26284719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indirect comparison and cost-utility of dabigatran etexilate and rivaroxaban in the treatment and extended anticoagulation of venous thromboembolism in a UK setting.
    Jugrin AV; Hösel V; Ustyugova A; De Francesco M; Lamotte M; Sunderland T
    J Med Econ; 2016; 19(1):1-10. PubMed ID: 26390231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep Vein Thrombosis in Intensive Care.
    Boddi M; Peris A
    Adv Exp Med Biol; 2017; 906():167-181. PubMed ID: 27628009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.